Home › Stargardt Disease › Michigan › Ann Arbor
Stargardt Disease clinical trials in Ann Arbor, MI
4 studies for Stargardt Disease are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
RecruitingObservational study
- University of Michigan Health - Kellogg Eye Center, Ann Arbor
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
RecruitingObservational study
- University of Michigan Kellogg Eye Center, Ann Arbor
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
RecruitingPhase 1/2
- University of Michigan Kellogg Eye Center, Ann Arbor
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
RecruitingObservational study
- Kellogg Clinical Research Center, Ann Arbor
Stargardt Disease trials in other cities
- Dallas, TX9 studies
- Boston, MA5 studies
- Phoenix, AZ4 studies
- Houston, TX4 studies
- Cincinnati, OH4 studies
- Gainesville, FL4 studies
- Miami, FL4 studies
- Portland, OR4 studies
- Baltimore, MD3 studies
- Pittsburgh, PA3 studies
- Aurora, CO3 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.